Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss
S Barja-Fernandez,1–3 R Leis,2 FF Casanueva,3,4 LM Seoane1,3 1Grupo Fisiopatología Endocrina, 2Departamento de Pediatría, Universidad de Santiago de Compostela (USC), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalar...
Saved in:
Main Authors: | Barja-Fernandez S (Author), Leis R (Author), Casanueva FF (Author), Seoane LM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Efficacy of Glucomannan for Weight Loss in Overweight and Moderately Obese Adults
by: Joyce K. Keithley, et al.
Published: (2013) -
Safety and efficacy of health supplement for weight loss
by: Saliza Ibrahim, et al.
Published: (2016) -
Safety and efficacy of pharmacologic weight loss in patients with cirrhosis
by: Ali Y. Fakhreddine, et al.
Published: (2021) -
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
by: Vázquez-Espinosa E, et al.
Published: (2015) -
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety
by: Hong D, et al.
Published: (2014)